Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. Regeneron Pharmaceuticals... 13 KB (1,182 words) - 04:42, 13 April 2024 |
 | FDA in March 2017 and is reported to cost $37,000 per year. Kevzara (sarilumab injection) is an interleukin-6 (IL-6) receptor antagonist for treatment... 26 KB (2,239 words) - 07:47, 14 April 2024 |
pathway by gefitinib tumor growth was decreased both in vitro and in vivo. Sarilumab was approved by US FDA in 2017 for rheumatoid arthritis. Several agents... 12 KB (1,289 words) - 19:20, 4 December 2023 |
Pharmaceuticals. Jevtana (Cabazitaxel), for prostate cancer. Kevzara (Sarilumab), for blood tests, lung and prostate cancer, marketed by Regeneron. Libtayo... 90 KB (8,728 words) - 08:35, 25 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 22 KB (1,841 words) - 14:41, 23 April 2024 |
Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab... 3 KB (367 words) - 15:37, 25 January 2024 |
Pegcetacoplan Ponesimod Ravulizumab Risankizumab Ritlecitinib Rozanolixizumab Sarilumab Satralizumab Siltuximab Siponimod Sirukumab Spesolimab Sutimlimab Tildrakizumab... 7 KB (271 words) - 15:59, 7 February 2024 |
saralasin (INN) sarcolysin (INN) saredutant (INN) Sarenin sargramostim (INN) sarilumab (USAN) saripidem (INN) Sarisol sarizotan (USAN) sarmazenil (INN) sarmoxicillin... 6 KB (341 words) - 15:24, 20 March 2022 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 14 KB (1,017 words) - 05:42, 14 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 22 KB (2,577 words) - 06:53, 17 April 2024 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 23 KB (1,806 words) - 03:46, 17 April 2024 |
 | rituximab chimeric monoclonal antibody against CD20 on B-cell surface bDMARD sarilumab IL-6 receptor antagonist bDMARD secukinumab IL-17 inhibitor bDMARD sulfasalazine... 9 KB (835 words) - 03:16, 15 February 2024 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 41 KB (3,462 words) - 05:59, 25 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 15 KB (1,152 words) - 06:14, 7 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 49 KB (6,005 words) - 11:09, 8 February 2024 |
 | rescue therapy in a patient with COVID-19 with no complete response to sarilumab". Infection. 48 (5): 767–771. doi:10.1007/s15010-020-01476-7. PMC 7340855... 43 KB (3,612 words) - 19:32, 22 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 24 KB (2,070 words) - 07:13, 15 March 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 26 KB (3,305 words) - 06:50, 28 March 2024 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 16 KB (1,451 words) - 21:00, 23 April 2024 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 13 KB (1,478 words) - 06:37, 13 March 2024 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 5 KB (267 words) - 03:30, 20 April 2024 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 14 KB (1,145 words) - 06:41, 10 April 2024 |
 | CD200 cancer Samrotamab vedotin mab chimeric/ humanized LRRC15 cancer Sarilumab Kevzara mab human IL-6 Y rheumatoid arthritis, ankylosing spondylitis... 133 KB (3,983 words) - 02:16, 19 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 23 KB (2,548 words) - 19:00, 2 April 2024 |
Morolimumab Namilumab Oleclumab Oxelumab§ Pamrevlumab Placulumab Relatlimab† Sarilumab Sifalimumab Tabalumab Tezepelumab Ulocuplumab Varlilumab Immune activation:... 38 KB (4,304 words) - 20:57, 1 December 2023 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 18 KB (2,082 words) - 08:54, 18 March 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 14 KB (1,578 words) - 14:00, 26 February 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 24 KB (3,008 words) - 11:28, 8 March 2024 |
COVID-19 in the UK: Two anti-inflammatory medications, tocilizumab and sarilumab, are found to cut deaths by a quarter in patients who are sickest with... 347 KB (33,588 words) - 08:02, 5 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 43 KB (4,986 words) - 09:18, 24 March 2024 |